US Stock MarketDetailed Quotes

RPHM Reneo Pharmaceuticals

Watchlist
  • 1.660
  • +0.010+0.61%
Close Mar 28 16:00 ET
  • 1.660
  • 0.0000.00%
Post 16:25 ET
55.48MMarket Cap-658P/E (TTM)

About Reneo Pharmaceuticals Company

Reneo Pharmaceuticals, Inc. is a clinical-stage company, which engages in the research and development of therapies for rare genetic mitochondrial diseases. The company was founded by Michael G. Grey and Niall O'Donnell on September 22, 2014 and is headquartered in San Diego, CA.

Company Profile

SymbolRPHM
Company NameReneo Pharmaceuticals
Listing Date04/09/2021
Issue Price15.00
Founded2014
CEOMr. Gregory J. Flesher
MarketNASDAQ
Employees48
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address18575 Jamboree Road,Suite 275
CityIrvine
ProvinceCalifornia
CountryUnited States of America
Zip Code92612
Phone1-858-283-0280

Company Executives

  • Name
  • Position
  • Salary
  • Gregory J. Flesher
  • President, Chief Executive Officer and Director
  • 1.19M
  • Wendy S. Johnson
  • Chief Business Officer
  • 458.40K
  • Ashley Hall
  • Chief Development Officer
  • 825.30K
  • Alejandro Dorenbaum
  • Chief Medical Officer
  • 477.65K
  • Michael Cruse
  • Chief Operating Officer
  • 781.47K
  • Jennifer P. Lam
  • Principal Financial Officer, Principal Accounting Officer and Senior Vice President of Finance
  • --
  • Michael Grey
  • Executive Chairman of the Board
  • 125.73K
  • Paul W. Hoelscher
  • Director
  • 262.93K
  • Dr. Niall O’Donnell, PhD
  • Director
  • 65.73K
  • Roshawn A. Blunt
  • Director
  • 91.73K
  • Edward T. Mathers
  • Independent Director
  • 75.73K
  • Stacey D. Seltzer
  • Independent Director
  • 75.56K
  • Dr. Eric M. Dube, PhD
  • Independent Director
  • 79.94K
  • Dr. Bali Muralidhar, M.D.,PhD
  • Independent Director
  • 25.73K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg